| Product NDC: | 68516-3603 |
| Proprietary Name: | AlphaNine |
| Non Proprietary Name: | COAGULATION FACTOR IX (HUMAN) |
| Active Ingredient(s): | & nbsp; COAGULATION FACTOR IX (HUMAN) |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68516-3603 |
| Labeler Name: | Grifols Biologicals Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103249 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19901231 |
| Package NDC: | 68516-3603-2 |
| Package Description: | 1 KIT in 1 CARTON (68516-3603-2) * 10 mL in 1 VIAL (68516-3606-2) * 10 mL in 1 VIAL, SINGLE-DOSE (63323-185-10) |
| NDC Code | 68516-3603-2 |
| Proprietary Name | AlphaNine |
| Package Description | 1 KIT in 1 CARTON (68516-3603-2) * 10 mL in 1 VIAL (68516-3606-2) * 10 mL in 1 VIAL, SINGLE-DOSE (63323-185-10) |
| Product NDC | 68516-3603 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | COAGULATION FACTOR IX (HUMAN) |
| Dosage Form Name | KIT |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19901231 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Biologicals Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |